Skip to content

A clinical trail to study the effect of two drugs,Laghuphala ghrita and changeryadi ghrita in Prasramsini yonivyapad.

Efficacy of Laghuphala ghrita yoni pichu with ashwagandha ksheerpaka in comparision to changeryadi ghrita yonipichu with ashwagandha ksheerapaka in the management of Prasramsini yonivyapad- An open label double arm randomized control clinical trail. - No

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109857
Enrollment
30
Registered
2026-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N819- Female genital prolapse, unspecified

Interventions

None listed

Sponsors

Dr Shilista Singh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects diagnosed with Prashramsini Yonivyapad first and second degree uterine prolapse. 2.With or without cystocoele 3.Married women of age group 30-60 years

Exclusion criteria

Exclusion criteria: 1.3rd degree uterine prolapse and Procidentia 2.Patients with systemic disorder like diabetes mellitus,bronchial asthma,lung disease,tuberculosis,muscular dystrophy,severe anaemia and jaundice. 3.Patient with genital tract infection i.e pelvic inflammatory diseases,cervicitis. 4.Patient having any benign and malignant growth of genital tract like Bartholin cyst, polyp fibroid,Gartner cyst,carcinomatous growth. 5.Psychologically unstable patient. 6.Patient with HIV,VDRL.HBsAg positive. 7.Patient with any surgical history of the genital tract.

Design outcomes

Primary

MeasureTime frame
1.Reduction in symptoms of 1st and 2nd degree uterine prolapse using POP-Q (Pelvic organ prolapse quantification). 2.Assessing strength of pelvic floor muscles using by Modified oxford grading scale.Timepoint: Assessment will be done before treatment and on 15th day for 2 consecutive cycle

Secondary

MeasureTime frame
Improved Quality of life by reducing the symptoms of Prasramshini Yonivyapad 1st and 2nd degree uterine prolapseTimepoint: Assessment will be done before treatment and on 15th day for 2 consecutive cycle

Countries

India

Contacts

Public ContactDr Shilista Singh

SHRI DHARAMASTHALA MANJUNATHESHWARA INSTITUTE OF AYURVEDA AND HOSPITAL, BENGALURU

drshweta@sdmayurbangalore.in9535201172

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026